New Data Support ctDNA-Guided Treatment in CRC

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in early-stage colorectal cancer.
Medscape Medical News

source https://www.medscape.com/viewarticle/ctdna-testing-shows-promise-guiding-crc-treatment-decisions-2025a10002bx?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?